← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nubad, Llc
Greer, SC
$17,738,846
Total funding
17
Grants
Funding over time
peak $3.5M · FY2011–24$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,738,846 · 17
By mechanism
R42$7,594,029 · 3
R41$4,654,479 · 8
R44$2,989,181 · 1
R43$2,501,157 · 5
Investigators at Nubad, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Aminoglycosides with reduced ototoxicity$999,986
R42 · FY2021 · AI
Development of peptide nucleic acid antibiotics$999,985
R42 · FY2021 · AI
Ototoxicity of modified aminoglycosides$999,976
R44 · FY2023 · AI
Ototoxicity of modified aminoglycosides$999,975
R44 · FY2024 · AI
Aminoglycosides with reduced ototoxicity$999,707
R42 · FY2023 · AI
Aminoglycosides with reduced ototoxicity$999,707
R42 · FY2024 · AI
Development of peptide nucleic acid antibiotics$999,557
R42 · FY2023 · AI
Development of peptide nucleic acid antibiotics$998,585
R42 · FY2024 · AI
Ototoxicity of modified aminoglycosides$989,230
R44 · FY2022 · AI
A Rapid Assay for RNA Targeted Drugs$684,746
R42 · FY2014 · GM
A Rapid Assay for RNA Targeted Drugs$663,747
R42 · FY2015 · GM
Delivery of chemically modified PNA oligomers$473,508
R41 · FY2021 · AI
Aminoglycosides with reduced ototoxicity via miRNA targeting$397,674
R41 · FY2020 · AI
Nucleobase aminosugars with reduced ototoxicity$364,433
R41 · FY2019 · DC
Screening the Ribosome for New Target Sites$325,000
R41 · FY2016 · AI
Screening the Ribosome for New Target Sites$325,000
R41 · FY2017 · AI
Nucleobase aminosugars with reduced ototoxicity$305,919
R41 · FY2018 · DC
Aminoglycosides with reduced ototoxicity$300,000
R41 · FY2016 · AI
Aminoglycosides with reduced ototoxicity via miRNA targeting$300,000
R41 · FY2019 · AI
Aminoglycosides with reduced ototoxicity$300,000
R41 · FY2017 · AI